The National Institute of Allergies and Infectious Diseases is leading COVID-19 clinical trial efforts through a large-scale network, called the COVID-19 Prevention Network (CoVPN). Dr. Jim Kublin, the executive director of operations program for CoVPN, shares more about this government-funded clinical trials network for COVID-19, the importance of diversity in research, and how tech is rapidly advancing medical discoveries.
HealthCast
Season 2
Episode 1
23m listen
Ensuring Participant Diversity in COVID-19 Vaccine Trials
Modern technology has the power to overcome clinical trial participation challenges.
-
Dr. Jim Kublin Executive Director of Operation Programs CoVPN
Related Content
-
DHS Leads Government’s Largest Civilian AI Hiring Effort
On this AI GovCast miniseries, Boyce discusses his journey to the agency with his prior roles at the Office of Management and Budget.
15m listen -
Storytelling Miniseries: Using Narratives to Nurture Relationships
In the final episode of our Storytelling Miniseries, we discuss building meaningful relationships through storytelling.
20m listen -
How AI Improves Decision-Making and Workload at Borders
Customs and Border Protection CTO Sunil Madhugiri discussed how the agency is using artificial intelligence at the nation’s borders.
19m listen -
Quantum, Workforce Issues Lead FDA’s Digital Transformation
The FDA is taking a proactive approach to its digital transformation efforts that its tech leaders highlighted in a new IT strategy.
14m listen
